FDA
approval
· 2013-12-12
FDA Approved: ULORIC — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
Summary
FDA approved a supplemental application for ULORIC (febuxostat) by Takeda Pharmaceuticals America, Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ULORIC (FEBUXOSTAT)